AVITA Medical Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
BofA Securities Reiterates Buy Rating on Avita Medical Ltd. (RCEL)
May 14, 2024 8:48 AM EDTBofA Securities analyst Lyanne Harrison reiterated a Buy rating and $21.00 price target on Avita Medical Ltd. (NASDAQ: RCEL).
The analyst comments "We reiterate our Buy; PO unchanged at US$21/A$6. We expect AVITA will gain momentum as the year progresses, driven by short term... More
AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 41c
May 13, 2024 4:04 PM EDTAVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.73), $0.41 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.02 million.
For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.
... More